JPRN-jRCT2080221342未知1 期
Multiple-Dose, Dose-Escalation Study to Evaluate
适应症
试验速览
- 阶段
- 1 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Have given written informed consent
- •-Women must not be pregnant, breastfeeding or be at risk to become pregnant during study participation
- •-Diagnosis of Rheumatoid Arthritis
- •-Active Rheumatoid Arthritis
- •-Current, regular use of Methotrexate, at a stable dose
- •-Body weight between 40 and 105 kg, inclusive
排除标准
- •-Use of excluded medications (reviewed by study doctor)
- •-Have medical findings which, in the opinion of the study doctor, put patient at an unacceptable risk for participation in the study
- •-Have had recent or ongoing infection which, in the opinion of the study doctor put patient at an unacceptable risk for participation
- •-Evidence of tuberculosis
- •-Have systemic inflammatory condition other than RA
研究者
相似试验
招募中
1 期
Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease (I8G-MC-LMDD)Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's DiseaseJPRN-jRCT2080223501Eli Lilly Japan K.K.
未知
1 期
Multiple-Dose, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2439821 in Japanese Patients with Rheumatoid Arthritis on Concomitant Methotrexate TreatmentRheumatoid ArthritisJPRN-jRCT2080221108Eli Lilly Japan K.K.
已完成
1 期
A study in healthy subjects to see the effects of the test medicine ALKS 2680 in single and multi-dose regimePhase 1 drug studyNervous System DiseasesISRCTN98204977Alkermes (United States)147
进行中（未招募）
1 期
Single and Multiple Dose Study of MK-0616 in Healthy Japanese ParticipantsHypercholesterolemiaJPRN-jRCT2031210233Tanaka Yoshiyuki48
已完成
1 期
Single and Multiple Dose Study of MK-5475 in Healthy ParticipantsPulmonary HypertensionJPRN-jRCT2031210073Tanaka Yoshiyuki48